Laurus Labs Limited (LAURUSLABS.BO)

447.30 -2.40 (-0.53%) At close: 03:54PM IST

Laurus Labs Limited

Serene Chambers
2nd Floor Road No. 7 Banjara Hills
Hyderabad 500034
India
91 40 3980 4333
https://www.lauruslabs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Satyanarayana Chava M.Sc., Ph.D.	CEO & Whole Time Director	186.44M	N/A	1961
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.	CFO & Whole-Time Director	49.65M	N/A	1965
Mr. B. V. R. K. Suryadevara Srinivasa Rao	Executive Vice President of Manufacturing & Operations	N/A	N/A	1968
Mr. Gogireddy Venkateswar Reddy	Asst. VP of Legal & Secretarial, Compliance Officer & Company Secretary	N/A	N/A	N/A
Mr. Narasimha Rao Chava	Senior Vice President of Human Resources	N/A	N/A	1968
Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D.	Head of Quality & Executive Director	33M	N/A	1962
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc.	Senior Vice President of Manufacturing	N/A	N/A	1963
Mr. Chagarlamudi Sita Ramaiah	Senior Vice President of Finance	N/A	N/A	1973
Mr. Dammalapati Venkata Lakshmi Narasimha Rao	Senior Vice President of Synthesis	N/A	N/A	1969
Mr. Rajaram Iyer M.B.A.	Senior Vice President of Portfolio Management	N/A	N/A	1974

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Corporate governance

Laurus Labs Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.